So I think she may be a unicorn but pretty cool story
That transparency makes it easier to feel confident about what you're putting in your body
#Type2Diabetes #DiabetesCare #GLP1 #Semaglutide #Tirzepatide #SGLT2Inhibitors #Endocrinology #PharmaMarketIntelligence #MarketResearch #DrugDevelopment #Biopharma #CardiometabolicHealth #HealthcareInnovation #PharmaCommercial To view or add a comment, sign in Kailera Therapeutics Therapeutics has reported positive Phase 3 results for oral GLP-1 candidate KAI-7535 in obesity and type 2 diabetes, although high gastrointestinal event rates remain a major commercial and clinical concern.#KaileraTherapeutics #KAI7535 #GLP1 #ObesityTreatment #Type2Diabetes #ClinicalTrials #Biotechnology #WeightLoss #MetabolicDisease #KLRA To view or add a comment, sign in Tsunami of LDL-lowering drugs, yet a high incidence of vascular plaques and heart attacks is still killing people
For patients with stable, well-controlled Hashimoto's disease on established levothyroxine therapy, NICE guidance (NG145) typically recommends thyroid function testing annually
Join 35,000+ patients who lost an average of 15-20% of their body weight
References: Garcia JM, Merriam GR, Kargi AY